Synonym
L-Histidyl hydrazide; AG01; AG-01; AG 01; Histidine hydrazide;
IUPAC/Chemical Name
(2S)-2-Amino-3-(1H-imidazol-5-yl)propanehydrazide
InChi Key
HIQSHBQGIXVMBC-YFKPBYRVSA-N
InChi Code
InChI=1S/C6H11N5O/c7-5(6(12)11-8)1-4-2-9-3-10-4/h2-3,5H,1,7-8H2,(H,9,10)(H,11,12)/t5-/m0/s1
SMILES Code
N[C@@H](CC1=CNC=N1)C(NN)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
169.19
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Babizhayev MA, Kasus-Jacobi A. State of the art clinical efficacy and safety
evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the
delivery, self-bioactivation, molecular targets and interaction with a highly
evolved histidyl-hydrazide structure in the treatment and therapeutic management
of a group of sight-threatening eye diseases. Curr Clin Pharmacol. 2009
Jan;4(1):4-37. PubMed PMID: 19149498.
2: Babizhayev MA, Guiotto A, Kasus-Jacobi A. N-Acetylcarnosine and
histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of
senile cataracts and diabetic ocular complications. J Drug Target. 2009
Jan;17(1):36-63. doi: 10.1080/10611860802438736 . PubMed PMID: 19037813.
3: Abdo MR, Joseph P, Boigegrain RA, Montero JL, Köhler S, Winum JY. Brucella
suis histidinol dehydrogenase: synthesis and inhibition studies of substituted
N-L-histidinylphenylsulfonyl hydrazide. J Enzyme Inhib Med Chem. 2008
Jun;23(3):357-61. doi: 10.1080/14756360701617107 . PubMed PMID: 18569340.
4: Guiotto A, Ruzza P, Babizhayev MA, Calderan A. Malondialdehyde scavenging and
aldose-derived Schiff bases' transglycation properties of synthetic
histidyl-hydrazide carnosine analogs. Bioorg Med Chem. 2007 Sep
15;15(18):6158-63. Epub 2007 Jun 20. PubMed PMID: 17604632.
5: Roe MR, Xie H, Bandhakavi S, Griffin TJ. Proteomic mapping of 4-hydroxynonenal
protein modification sites by solid-phase hydrazide chemistry and mass
spectrometry. Anal Chem. 2007 May 15;79(10):3747-56. Epub 2007 Apr 17. PubMed
PMID: 17437329.
6: Han B, Stevens JF, Maier CS. Design, synthesis, and application of a
hydrazide-functionalized isotope-coded affinity tag for the quantification of
oxylipid-protein conjugates. Anal Chem. 2007 May 1;79(9):3342-54. Epub 2007 Mar
27. PubMed PMID: 17385840.
